- Home
- IRON vs CNMD Comparison
IRON vs CNMD Comparison
Compare IRON & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- CNMD
- Stock Information
- Founded
- IRON 2017
- CNMD 1970
- Country
- IRON United States
- CNMD United States
- Employees
- IRON N/A
- CNMD N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- IRON Health Care
- CNMD Health Care
- Exchange
- IRON Nasdaq
- CNMD Nasdaq
- Market Cap
- IRON 1.9B
- CNMD 2.2B
- IPO Year
- IRON N/A
- CNMD 1987
- Fundamental
- Price
- IRON $52.23
- CNMD $58.93
- Analyst Decision
- IRON Strong Buy
- CNMD Buy
- Analyst Count
- IRON 10
- CNMD 5
- Target Price
- IRON $83.80
- CNMD $77.20
- AVG Volume (30 Days)
- IRON 342.1K
- CNMD 494.4K
- Earning Date
- IRON 05-08-2025
- CNMD 04-23-2025
- Dividend Yield
- IRON N/A
- CNMD 1.33%
- EPS Growth
- IRON N/A
- CNMD 108.33
- EPS
- IRON N/A
- CNMD 4.25
- Revenue
- IRON N/A
- CNMD $1,307,015,000.00
- Revenue This Year
- IRON N/A
- CNMD $5.97
- Revenue Next Year
- IRON N/A
- CNMD $5.63
- P/E Ratio
- IRON N/A
- CNMD $14.14
- Revenue Growth
- IRON N/A
- CNMD 5.00
- 52 Week Low
- IRON $25.60
- CNMD $55.22
- 52 Week High
- IRON $68.73
- CNMD $81.22
- Technical
- Relative Strength Index (RSI)
- IRON 44.88
- CNMD 44.03
- Support Level
- IRON $51.57
- CNMD $58.92
- Resistance Level
- IRON $53.61
- CNMD $61.25
- Average True Range (ATR)
- IRON 2.00
- CNMD 2.01
- MACD
- IRON 0.06
- CNMD 0.28
- Stochastic Oscillator
- IRON 36.43
- CNMD 24.78
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.